Sunday, March 31st, 2013 at 12:49 PM
A recently concluded research study has revealed that obstructive sleep apnea, a common form of sleep-disordered breathing (SDB), is associated with increased rates of ADHD-like behavioral problems in children as well as other adaptive and learning problems.
“This study provides some helpful information for medical professionals consulting with parents about treatment options for children with SDB that, although it may remit, there are considerable behavioral risks associated with continued SDB,” said Michelle Perfect, PhD, the study’s lead author and assistant professor in the school psychology program in the department of disability and psychoeducational studies at the University of Arizona in Tucson. Read the rest of this entry
Thursday, February 7th, 2013 at 12:48 PM
According to Dr. Paulose, a plastic and laser surgeon, yoga does not cure sleep apnea, but it can help reduce symptoms. He suggests the ujjayi pranayama, or hissing breath, to increase lung capacity and remove throat blockages. Sit in a lotus position, breathe deeply through your nostrils until calm, then inhale forcefully through the nostrils while contracting your neck muscles to produce a low, throbbing sound. Hold this inhaled breath as long as possible, then close one nostril with your fingers and slowly exhale through the other nostril. Repeat with the other nostril and perform three to five times each day. Read the rest of this entry
Saturday, February 2nd, 2013 at 1:40 PM
Results of epidemiological studies have shown that chronic obstructive pulmonary disease (COPD) is frequently associated with comorbidities, the most serious and prevalent being cardiovascular disease, lung cancer, osteoporosis, muscle weakness, and cachexia.
Mechanistically, environmental risk factors such as smoking, unhealthy diet, exacerbations, and physical inactivity or inherent factors such as genetic background and ageing contribute to this association.
No convincing evidence has been provided to suggest that treatment of COPD would reduce comorbidities, although some indirect indications are available. Clear evidence that treatment of comorbidities improves COPD is also lacking, although observational studies would suggest such an effect for statins, ? blockers, and angiotensin-converting enzyme blockers and receptor antagonists.
Large-scale prospective studies are needed. Reduction of common risk factors seems to be the most powerful approach to reduce comorbidities.
Whether reduction of so-called spill-over of local inflammation from the lungs or systemic inflammation with inhaled or systemic anti-inflammatory drugs, respectively, would also reduce COPD-related comorbidities is doubtful. [TheLancet.com]
Sunday, January 20th, 2013 at 1:11 PM
Along with obstructive sleep apnea, central sleep apnea is one of the two main forms of sleep apnea, a dangerous class of sleep disorders characterized by an interruption of breathing of 10 seconds or more numerous times an hour during sleep.
Dangers of Central Sleep Apnea
Although central sleep apnea is less common than obstructive sleep apnea, it is just as dangerous.
Central sleep apnea can result in severe morning headaches, daytime fatigue, anxiety, depression, short-term memory problems and difficulty focusing. Read the rest of this entry
Monday, October 17th, 2011 at 10:22 PM
SleepApneaDisorder/ [ Press Release ]/ Versailles, Ohio /October 17, 2011/ Sleep Apnea: A Growing Health Concern According to the National Institute of Neurological Disorders and Strokes, an estimated 18 million Americans have sleep apnea. However, few of them have had the problem diagnosed.
Sleep apnea is the repeated interruption of normal breathing during sleep. Obstructive sleep apnea is the most common type of breathing-related sleep disorder. In patients with OSA, the airway collapses, temporarily restricting airflow to the lungs. This partial airway obstruction causes the upper airway tissue to vibrate and produce the sound of the classic snore.
As OSA develops, it has a cumulative effect, meaning that the longer the disease goes untreated, the greater the negative side effects and associated health risks. According to numerous research studies, if sleep apnea remains untreated, other health conditions may emerge or current health problems may worsen, including: Read the rest of this entry
Tuesday, July 5th, 2011 at 10:33 PM
One in five patients diagnosed with pulmonary arterial hypertension (PAH) in the United States report symptoms for more than 2 years before diagnosis.
PAH is a progressive and fatal disorder, and the disease is often advanced when recognized, especially in younger patients.
Researchers from Intermountain Medical Center, the University of California, University of Pennsylvania, Baylor College of Medicine, Boston University, and Mayo Clinic studied 2,967 adult patients enrolled in the Registry to Evaluate Early Long-term PAH Disease Management (REVEAL), for an 18-month period. In 21.1% of patients, symptoms were experienced for more than two years before PAH was recognized.
History of obstructive airways disease and sleep apnea were independently associated with delayed PAH recognition. Despite progress in understanding the cellular and genetic basis of PAH, researchers found that the onset of PAH before age 36 years was associated with the greatest likelihood of delayed disease recognition, especially in individuals with histories of common respiratory disorders. This article is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: Chest. 2011;140(1):19-26.
Wednesday, June 8th, 2011 at 2:34 PM
NeuroTrials Research, an independent research organization in Atlanta devoted to investigational drug, medical device, consumer research and diagnostic testing, has been selected to conduct two new clinical research studies of an investigational sleep medication on the breathing function of participants with Chronic Obstructive Pulmonary Disorder (COPD) or Obstructive Sleep Apnea (OSA).
Nationally recognized physicians and researchers founded NeuroTrials over a decade ago. NeuroTrials continues to attract important early phase- phase IV studies that impact the health and welfare of residents in Atlanta and nationwide. Over 24 million Americans have been diagnosed with COPD and as many as 1 in 3 American men suffer from OSA. Read the rest of this entry
Tuesday, May 31st, 2011 at 2:37 PM
A study conducted in Las Vegas has found that of the 106 patients on which the CPAP mask was tried since February, 70 percent benefited, with medical officials reporting that the patients did not have to go on a mechanical ventilator.
“CPAP was highly effective in the treatment of dyspnea (difficult or labored breathing) associated with asthma, chronic obstructive pulmonary disease, congestive heart failure, and pneumonia,” states a preliminary report written by Bledsoe and Johnson to the Southern Nevada Health District.
Those conditions generally see a fluid buildup in the lungs. CPAP’s continuous positive pressure of air, pushing the fluid back into the soft tissue, allows gas exchange to flow better and simplifies a patient’s ability to take a breath.
If the preliminary results of the Las Vegas study stay about the same for about 300 patients, it’s expected that the health district will require the CPAP on all emergency medical service vehicles in Southern Nevada. Read the rest of this entry
Wednesday, May 4th, 2011 at 3:50 PM
Reportlinker announces that a new market research report The Respiratory Diagnostic Devices Market Outlook to 2016 . This report covers the epidemiology of the key respiratory disorders forecasting this to 2016. The report then goes on to give in depth analysis of the major diagnostic technologies including: blood gas analyzers, pulse oximeters, spirometers, full spectrum testing equipment, and polysomnographs. For each of these technology types an overview is given of the leading players and their products.
Tuesday, April 19th, 2011 at 9:08 PM
SleepApneaDisorder/ [ Press release ]/ LYMAN, S.C., April 19, 2011 /- Southern Home Medical Equipment, Inc. a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, announced today that in response to the growing demand for specialized solutions for respiratory therapy illnesses, Southern Home has launched its Respi-Care Respiratory Therapy Program. The program provides specialized treatment for Sleep Apnea, bronchodilator therapy, tracheostomy care and other respiratory illnesses.
Respi-Care combines the expertise of certified respiratory therapists with the latest in respiratory therapy equipment, patient assessment and education to both the patient and health care staff. The Respi-Care treatment program is provided to patients through home health, skilled nursing and other facilities. Read the rest of this entry